SEI Investments’s Akero Therapeutics AKRO Stock Holding History

SEI Investments’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,131	Closed	-$813K	–	3123
2025 Q3	$813K	Buy	17,131 +5,529	+48%	+$268K	﹤0.01%	2046
2025 Q2	$619K	Sell	11,602 -5,177	-31%	-$235K	﹤0.01%	2097
2025 Q1	$679K	Buy	16,779 +5,892	+54%	+$250K	﹤0.01%	2036
2024 Q4	$303K	Buy	+10,887	New	+$330K	﹤0.01%	2353
2023 Q4	–	Sell	-18,908	Closed	-$956K	–	2612
2023 Q3	$956K	Buy	18,908 +5,284	+39%	+$246K	﹤0.01%	1898
2023 Q2	$636K	Buy	13,624 +2,024	+17%	+$92.8K	﹤0.01%	2046
2023 Q1	$444K	Sell	11,600 -3,678	-24%	-$164K	﹤0.01%	2177
2022 Q4	$837K	Sell	15,278 -673	-4%	-$28.8K	﹤0.01%	1827
2022 Q3	$543K	Buy	+15,951	New	+$244K	﹤0.01%	2053
2020 Q4	–	Sell	-12,969	Closed	-$399K	–	2450
2020 Q3	$399K	Buy	+12,969	New	+$453K	﹤0.01%	1984

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SEI Investments's AKRO Position: Q4 2025 in Review

SEI Investments sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 17,131 shares — an estimated $813K sold.

SEI Investments first reported a position in AKRO in Q3 2020 and held it in 10 quarters. The position peaked at $956K in Q3 2023. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

SEI Investments reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
SEI Investments sold 17,131 Akero Therapeutics shares in Q4 2025, an estimated $813K.
SEI Investments first reported a position in Akero Therapeutics in Q3 2020 and held it in 10 quarters.
SEI Investments's Akero Therapeutics position peaked at $956K in Q3 2023.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on SEI Investments's 13F filing for Q4 2025, filed 13 Feb 2026.